📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MaxThera

1.1 - Company Overview

MaxThera Logo

MaxThera

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical research and development of new treatments for bacterial infections, especially those caused by drug-resistant bacteria.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MaxThera

PhagoMed Logo

PhagoMed

HQ: Austria Website
  • Description: Provider of a biotech platform for developing drugs and therapies, focusing on human therapeutic applications of phages and phage-derived proteins to address urinary tract infections and bacterial vaginosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PhagoMed company profile →
Alverix Logo

Alverix

HQ: United States Website
  • Description: Provider of low-cost handheld reader devices with laboratory-grade accuracy and precision; partnering with diagnostic and OEM manufacturers to increase test accuracy, improve portability of existing tests, and develop new assays for use in physician offices and laboratory outreach.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alverix company profile →
Virion Serion Logo

Virion Serion

HQ: Germany Website
  • Description: Provider of in-vitro diagnostic products for infectious disease detection—viral, bacterial, fungal, and parasitic—including classic tests recommended for quantified antibodies and products that allow simultaneous antibody detection against multiple antigens using flow cytometry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Virion Serion company profile →
Valneva Logo

Valneva

HQ: France Website
  • Description: Provider of prophylactic vaccines for infectious diseases, focusing on development and commercialization for unmet medical needs. Portfolio includes IXCHIQ (VLA1553), a live-attenuated, single-dose chikungunya vaccine approved in the U.S.; VLA15, a multivalent Lyme disease vaccine in Phase 3; and a tetravalent Shigella vaccine candidate developed with LimmaTech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Valneva company profile →
Chembio Diagnostics Logo

Chembio Diagnostics

HQ: United States Website
  • Description: Provider of proprietary rapid point-of-care diagnostic tests, developing, manufacturing, licensing and marketing DPP assays for HIV 1/2, HIV-Syphilis, Zika (IgM/IgG in Europe; IgM in the USA), Ebola antigen (USA), and Zika-Chikungunya-Dengue (Europe). Portfolio includes two FDA PMA-approved, CLIA-waived rapid HIV tests marketed in the U.S. by Alere (formerly Inverness Medical Innovations).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chembio Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MaxThera

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MaxThera

2.2 - Growth funds investing in similar companies to MaxThera

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MaxThera

4.2 - Public trading comparable groups for MaxThera

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MaxThera

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MaxThera

What does MaxThera do?

MaxThera is a provider of biopharmaceutical research and development of new treatments for bacterial infections, especially those caused by drug-resistant bacteria.

Who are MaxThera's competitors?

MaxThera's competitors and similar companies include PhagoMed, Alverix, Virion Serion, Valneva, and Chembio Diagnostics.

Where is MaxThera headquartered?

MaxThera is headquartered in United States.

How many employees does MaxThera have?

MaxThera has 1,000 employees 🔒.

When was MaxThera founded?

MaxThera was founded in 2010 🔒.

What sector and industry vertical is MaxThera in?

MaxThera is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MaxThera

Who are the top strategic acquirers in MaxThera's sector and industry

Top strategic M&A buyers and acquirers in MaxThera's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MaxThera?

Top strategic M&A buyers groups and sectors for MaxThera include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MaxThera's sector and industry vertical

Which are the top PE firms investing in MaxThera's sector and industry vertical?

Top PE firms investing in MaxThera's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MaxThera's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MaxThera's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MaxThera's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MaxThera include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MaxThera's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MaxThera?

The key public trading comparables and valuation benchmarks for MaxThera include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MaxThera for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MaxThera with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MaxThera's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MaxThera with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MaxThera's' sector and industry vertical?

Access recent funding rounds and capital raises in MaxThera's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MaxThera